BASAGLAR KwikPen insulin glargine (rbe) 100 IU/mL solution for injection cartridge

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

Insulin glargine, Quantity: 100 IU/mg

Disponible depuis:

Eli Lilly Australia Pty Ltd

DCI (Dénomination commune internationale):

Insulin glargine

forme pharmaceutique:

Injection, solution

Composition:

Excipient Ingredients: dilute hydrochloric acid; glycerol; sodium hydroxide; water for injections; metacresol; zinc oxide

Mode d'administration:

Subcutaneous

Unités en paquet:

2, 5, 10, 1

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Insulin glargine is an insulin analogue indicated for once-daily subcutaneous administration in the treatment of type 1 diabetes mellitus in adults and children and type 2 diabetes mellitus in adults who require insulin for the control of hypeglycaemia.

Descriptif du produit:

Visual Identification: Clear to colourless solution; Container Type: Cartridge; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Statut de autorisation:

Licence status A

Date de l'autorisation:

2014-11-21